Glaukos (GKOS) Equity Ratio (2014 - 2026)
Glaukos (GKOS) reported Equity Ratio of 0.75 for Q1 2026, down 5.02% year-over-year from 0.79 in Q1 2025, and up 2.27% on a QoQ basis from 0.73 in Q4 2025.
Glaukos (GKOS) has 13 years of Equity Ratio data on file, last reported at 0.75 in Q1 2026.
- Quarterly Equity Ratio fell 5.02% year-over-year to 0.75 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.75 (down 5.02% YoY) and the FY2025 annual result came in at 0.73, down 6.66% from the prior year.
- Equity Ratio improved to 0.75 in Q1 2026 per GKOS's latest filing, from 0.73 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.79 in Q1 2025 and bottomed at 0.48 in Q1 2024.
- The 5-year median for Equity Ratio is 0.57 (2022), against an average of 0.63.
- The widest annual swing landed in 2023, when Equity Ratio declined 7.95%; it then soared 63.73% in 2025.
- Tracing GKOS's Equity Ratio over 5 years: stood at 0.53 in 2022, then retreated by 7.13% to 0.49 in 2023, then jumped by 60.24% to 0.79 in 2024, then decreased by 6.66% to 0.73 in 2025, then rose by 2.27% to 0.75 in 2026.
- Per Business Quant, the three latest GKOS Equity Ratio figures stand at 0.75 (Q1 2026), 0.73 (Q4 2025), and 0.77 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 0.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.75 |
| Dec 31, 2025 | 0.73 |
| Sep 30, 2025 | 0.77 |
| Jun 30, 2025 | 0.78 |
| Mar 31, 2025 | 0.79 |
| Dec 31, 2024 | 0.79 |
| Sep 30, 2024 | 0.72 |
| Jun 30, 2024 | 0.72 |
| Mar 31, 2024 | 0.48 |
| Dec 31, 2023 | 0.49 |
| Sep 30, 2023 | 0.50 |
| Jun 30, 2023 | 0.51 |
| Mar 31, 2023 | 0.52 |
| Dec 31, 2022 | 0.53 |
| Sep 30, 2022 | 0.54 |
| Jun 30, 2022 | 0.55 |
| Mar 31, 2022 | 0.57 |
| Dec 31, 2021 | 0.56 |
| Sep 30, 2021 | 0.56 |
| Jun 30, 2021 | 0.56 |
| Mar 31, 2021 | 0.58 |
| Dec 31, 2020 | 0.66 |
| Sep 30, 2020 | 0.67 |
| Mar 31, 2020 | 0.82 |
| Dec 31, 2019 | 0.82 |
| Sep 30, 2019 | 0.62 |
| Jun 30, 2019 | 0.62 |
| Mar 31, 2019 | 0.81 |
| Dec 31, 2018 | 0.84 |
| Sep 30, 2018 | 0.86 |
| Jun 30, 2018 | 0.87 |
| Mar 31, 2018 | 0.88 |
| Dec 31, 2017 | 0.83 |
| Sep 30, 2017 | 0.87 |
| Jun 30, 2017 | 0.87 |
| Mar 31, 2017 | 0.89 |
| Dec 31, 2016 | 0.87 |
| Sep 30, 2016 | 0.85 |
| Jun 30, 2016 | 0.85 |
| Mar 31, 2016 | 0.84 |
| Dec 31, 2015 | 0.82 |
| Sep 30, 2015 | 0.81 |
| Jun 30, 2015 | 0.74 |
| Dec 31, 2014 | -6.18 |